Nature Communications

Co-delivery of sorafenib and an FSP1 inhibitor triggers dual ferroptosis in tumor cells and immunosuppressive macrophages for enhanced immunotherapy in mouse models of hepatocellular carcinoma

2025-11-18

Full text

DOI https://doi.org/10.1038/s41467-025-65056-9